Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. - Johnson,K.P.; Brooks,B.R.; Cohen,J.A.; Ford,C.C.; Goldstein,J.; Lisak,R.P. (Neurology, 1995)